Molecular-targeted therapies for ovarian cancer
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-10-01
著者
-
Kigawa Junzo
Department Of Obstetrics And Gynecology Seirei Hamamatsu Hospital
-
KIGAWA Junzo
Department of Obstetrics and Gynecology, Tottori University
関連論文
- Alterations of the TP53 Gene and TP53 Protein Expression in Epithelial Ovarian Cancer before and after Chemotherapy
- Enhanced Topoisomerase I Activity and Increased Topoisomerase IIα Content in Cisplatin-resistant Cancer Cell Lines
- P1-IS-35 Clear cell carcinoma of the ovary : retrospective analysis of Japan Clear Cell Carcinoma Study
- Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin : retrospective analysis
- The Behavior of Endometrial Hyperplasia : A Prospective Study
- Cisplatin-resistant HeLa Cells Are Resistant of Apoptosis via p53-dependent and -independent Pathways
- Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary : A potential treatment strategy
- Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed mullerian tumor of the fallopian tube
- Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma
- Expression of the c-myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer